TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Stock Mailbag: Enanta, Vanda, Pharmacyclics, Top 2014 Stock Catalysts

  • By Adam Feuerstein
  • Nov 22, 2013 6:00 AM EST
Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Grading the Twitterverse's 2013 Biotech Stock Picks

  • By Adam Feuerstein
  • Sep 16, 2013 9:29 AM EDT
CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

Leaders of <I>TheStreet's</I> Drug Approval Contest

  • By Adam Feuerstein
  • May 6, 2013 9:21 AM EDT
The Next Big Thing In Biotech: Decision Week
VIDEO

The Next Big Thing In Biotech: Decision Week

  • By Gregg Greenberg
  • Mar 21, 2013 9:23 AM EDT
Biotech Stock Mailbag: Ziopharm, Oncolytics, Sarepta
STOCKS

Best And Worst FDA Drug Approval Stocks of 2013

  • By Adam Feuerstein
  • Mar 12, 2013 8:00 AM EDT
Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics
STOCKS

Play TheStreet's FDA Drug Approval Contest

  • By Adam Feuerstein
  • Mar 5, 2013 12:05 PM EST
Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
STOCKS

Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta

  • By Adam Feuerstein
  • Feb 1, 2013 7:00 AM EST
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

A.P. Pharma Run-Up Trade Into FDA Approval Decision

  • By Mark Messier
  • Jan 22, 2013 8:32 AM EST
Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

2013 FDA Drug Approval Decision Calendar

  • By Adam Feuerstein
  • Dec 19, 2012 9:12 AM EST
Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

First 90 Days of 2013 Are Live or Die For These Biotech Stocks

  • By Adam Feuerstein
  • Nov 19, 2012 9:43 AM EST
Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS

AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades

  • By Mark Messier
  • Oct 9, 2012 7:05 AM EDT
Spectrum Pharma Implodes On Colossal Fusilev Sales Warning
STOCKS

Biotech Calendar: Key Dates for March

  • By Adam Feuerstein
  • Mar 2, 2011 8:15 AM EST
Neurocrine Licenses Drug to Abbott:BioBuzz
STOCKS

Biotech Sector Weekly Rewind

  • By Adam Feuerstein
  • Nov 20, 2010 8:00 AM EST
INVESTING

Ambac Financial, QAD: Early Volume Plays

  • By Robert Holmes
  • May 18, 2010 8:10 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

A.P. Pharma, Netlist: Early Volume Plays

  • By Robert Holmes
  • Mar 19, 2010 10:43 AM EDT
STOCKS

Biotech Stock Mailbag: Sequenom

  • By Adam Feuerstein
  • Mar 12, 2010 7:00 AM EST
INVESTING

Latest News in Activist Investing

  • By Stockpickr Staff
  • Feb 26, 2009 11:47 AM EST
Dating Sites: Best, Worst & Weirdest
OPINION

Insider Action: Trading Level 3

  • By Jonathan Moreland
  • Oct 3, 2008 12:47 PM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Monday's Small-Cap Winners & Losers

  • By Sarina Penn
  • Jun 25, 2007 4:40 PM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Thursday's Health Winners & Losers

  • By Althea Chang
  • Dec 21, 2006 1:08 PM EST
Dating Sites: Best, Worst & Weirdest
INVESTING

Monday's Small-Cap Winners & Losers

  • By TSC Staff
  • Oct 2, 2006 3:24 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.